Among the 30 IGS associated with at least 1 HLA-A*02:01 sequence logo peptide, 16 had hazard ratios >1.0 as expected for acute and chronic GVHD and <1.0 as expected for relapse. This evidence concerns the gene HLA-A and chronic graft versus host disease.